EMERALD ADVISERS, LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 37 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2013$4,577,000
-62.3%
118,242
-65.9%
0.25%
-63.8%
Q3 2013$12,141,000
+112.6%
346,984
-15.9%
0.69%
+97.1%
Q2 2013$5,712,000412,6960.35%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q2 2013
NameSharesValueWeighting ↓
Raging Capital Management, LLC 295,790$1,367,0000.20%
Jump Trading, LLC 42,400$196,0000.06%
GAM Holding AG 83,940$388,0000.02%
Magnus Financial Group LLC 13,393$62,0000.01%
PANAGORA ASSET MANAGEMENT INC 438,606$2,026,0000.01%
Quantamental Technologies LLC 3,898$18,0000.01%
QS Investors, LLC 155,683$719,0000.01%
SFMG, LLC 11,994$55,0000.01%
Winslow, Evans & Crocker, Inc. 4,060$20,0000.01%
MILLENNIUM MANAGEMENT LLC 812,262$3,753,0000.01%
View complete list of INSYS THERAPEUTICS INC NEW shareholders